Clinical trial
Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Administration of Nepadutant in Infant Colic
NCT01258153 is registered in ClinicalTrials.gov with Menarini Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Administration of Nepadutant in Infant Colic
- Lead sponsor
- Menarini Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- March 31, 2014
- Enrollment
- 115 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
infantile colic